InvestorsHub Logo
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

Re: None

Tuesday, 10/11/2022 11:55:13 AM

Tuesday, October 11, 2022 11:55:13 AM

Post# of 547
Here's a company, DICE Therapeutics, up 50% today, that could eventually be a competitor, that rose on the basis of the results of a Phase 1 study that its small molecule, which blocks IL17, significantly reduced Psoriasis in the study.
https://www.dicetherapeutics.com/about/
Looks to me that MyMD is way ahead of them.
Comments and observations welcomed!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News